Cangrelor intermediate 163706-61-4

Product Quick Detail

Minimum Order: 1

Packaging: 1kg/Fluoride bottle

Delivery: 15 Days

We manufacture and provide Cangrelor intermediate

CAS 163706-61-4

Purity is ≥ 98%

Cangrelor:

is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application. Some P2Y₁₂ inhibitors are used clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation.

Country: China (Mainland)
Business Type:
Market:
Founded Year:2013
Address:Building 9, No. 150, Cailun Road, Zhangjiang High-Tech Park, Shanghai, China
Contact:Chrissy Chen

*Your name:	Enter name here eg:Ralph zhang
*Your Email:	Enter email here
*To:	Shanghai Bocimed Pharmaceutical Co., Ltd.
*Subject:
*Message:
	Enter between 20 to 3,000 characters. English only. Characters : 0 / 3000
*Enter the secure code shown below	Reload Image